Trends in transcatheter and surgical aortic valve replacement in the United States, 2008-2018 - 26/11/21

Doi : 10.1016/j.ahj.2021.03.017

Katherine AA Clark, MD, MBA ^a,^{^{1
These authors contributed equally to this work}}, Fouad Chouairi, BS ^b,^{^{1
These authors contributed equally to this work}}, Bradley Kay, MD ^a, Samuel W Reinhardt, MD ^a, P Elliott Miller, MD ^a, Michael Fuery, MD ^c, Clancy W Mullan, MD ^d, Avirup Guha, MD ^e,^f, Tariq Ahmad, MD ^a,^g, Nihar R Desai, MD, MPH ^a,^g,^⁎
^a Division of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT
^b Yale University School of Medicine, New Haven, CT
^c Department of Internal Medicine, Yale University School of Medicine, New Haven, CT
^d Division of Cardiac Surgery, Yale University School of Medicine, New Haven, CT
^e Case Western Reserve University, Cleveland, OH
^f Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus, OH
^g Center for Outcomes Research and Evaluation, New Haven, CT

^⁎Reprint requests: Nihar R Desai, MD, MPH, Center for Outcomes Research and Evaluation, 330 Cedar Street, New Haven, CT 06510Center for Outcomes Research and Evaluation,330 Cedar StreetNew HavenCT06510

Riassunto

We conducted a retrospective study using the NIS database from 2008 to 2018 to examine the most contemporary national hospitalization trends of transcatheter (TAVR) and surgical (SAVR) aortic valve replacement regarding volume, patient and hospital demographics and economics, resource utilization, total cost of stay, and in-hospital mortality. We demonstrate that TAVR procedures have been performed on a slow by steadily diversifying patient population while volume has grown significantly, while in-hospital mortality, length of stay, discharge home, and costs have improved, whereas these metrics have generally remained stable for SAVR. These trends will likely drive continued TAVR adoption, greatly expanding the overall aortic stenosis patient population eligible for AVR.

Il testo completo di questo articolo è disponibile in PDF.

Mappa

Background

Materials and Methods

Data Source and Study Population

Statistical Methods

Funding, Research, and Creation

Credit Author Statement

Esportazione

Vol 243

P. 87-91 - gennaio 2022 Ritorno al numero

Articolo precedente

Impact of vomiting on P2Y12 platelet inhibition in patients with ST-elevation myocardial infarction: A prespecified subanalysis of the ON-TIME 3 trial
Anne??H. Tavenier, Renicus??S. Hermanides, Jan??Paul. Ottervanger, Svetlana??V. Belitser, Olaf.??H. Klungel, Arnoud??W.J. van ‘t Hof, ON-TIME 3 investigators

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

connettersi o creare un account

Trends in transcatheter and surgical aortic valve replacement in the United States, 2008-2018 - 26/11/21

Riassunto

Mappa

Citazioni Export

File

Contenuto

Il mio account

Aide & support

Dichiarazione CNIL